Neuberger Berman Group
TERN

Neuberger Berman Group’s Terns Pharmaceuticals TERN Stock Holding History

Neuberger Berman Group’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-480,740
Closed -$25.3M – 2409
2026
Q1 		$25.3M Buy
+480,740
New +$19.7M 0.02% 613

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Neuberger Berman Group's TERN Position: Q2 2026 in Review

Neuberger Berman Group sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 480,740 shares — an estimated $25.3M sold.

Neuberger Berman Group first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $25.3M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Neuberger Berman Group reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Neuberger Berman Group sold 480,740 Terns Pharmaceuticals shares in Q2 2026, an estimated $25.3M.
  • Neuberger Berman Group first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Neuberger Berman Group's Terns Pharmaceuticals position peaked at $25.3M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.